[x]閉じる

短縮URL
URL

研究業績

The Significance of CD109 Expression in Oropharyngeal Squamous Cell Carcinoma.

Tsutsumi S, Momiyama K, Ichinoe M, Kato T, Mogi S, Miyamoto S, Murakumo Y, Yamashita T. Anticancer Res. 2022 Apr;42(4):2061-2070. doi: 10.21873/anticanres.15687. PMID: 35347029

 

A case of solid-type pancreatic hamartoma presenting high apparent diffusion coefficient value: histopathological correlation and literature review.

Woo J, Haradome H, Adachi K, Iwai T, Nishizawa N, Murakumo Y, Kusano C, Kumamoto Y, Inoue Y, Ojiri H. Abdom Radiol (NY). 2022 Feb 16. doi: 10.1007/s00261-022-03442-3. Online ahead of print. PMID: 35171320

 

CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer.

Adachi K, Sakurai Y, Ichinoe M, Tadehara M, Tamaki A, Kesen Y, Kato T, Mii S, Enomoto A, Takahashi M, Koizumi W, Murakumo Y. Virchows Arch. 2021 Nov 11. doi: 10.1007/s00428-021-03230-2. Online ahead of print. PMID: 34762199

 

Upregulation of REV7 correlates with progression of malignant melanoma.

Hoshino A, Nakayama C, Jiang SX, Sakurai Y, Kato T, Numata Y, Umezawa A, Ichinoe M, Murakumo Y. Pathol Int. 2022 Jan;72(1):14-24. doi: 10.1111/pin.13174. Epub 2021 Oct 12. PMID: 34637584

 

Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer.

Yanagisawa N, Satoh T, Tabata KI, Tsumura H, Nasu Y, Watanabe M, Thompson TC, Okayasu I, Murakumo Y, Baba S, Iwamura M. Asian J Urol. 2021 Jul;8(3):280-288. doi: 10.1016/j.ajur.2020.06.004. Epub 2020 Jun 16. PMID: 34401335

 

Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy.

Kusuhara S, Igawa S, Ichinoe M, Nagashio R, Kuchitsu Y, Hiyoshi Y, Shiomi K, Murakumo Y, Saegusa M, Satoh Y, Sato Y, Naoki K. Thorac Cancer. 2021 May;12(10):1570-1578. doi: 10.1111/1759-7714.13945. Epub 2021 Apr 1. PMID: 33793071

 

Increased expression of REV7 in small cell lung carcinomas and its association with tumor cell survival and proliferation.

Sanoyama I, Sakurai Y, Ichinoe M, Hoshino A, Kesen Y, Kato T, Numata Y, Umezawa A, Jiang SX, Murakumo Y. Pathol Int. 2021 Jan;71(1):15-23. doi: 10.1111/pin.13040. Epub 2020 Oct 28. PMID: 33112501

 

CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.

Taki T, Shiraki Y, Enomoto A, Weng L, Chen C, Asai N, Murakumo Y, Yokoi K, Takahashi M, Mii S. Cancer Sci. 2020 Dec;111(12):4616-4628. doi: 10.1111/cas.14673. Epub 2020 Oct 24. PMID: 33007133

 

Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer.

Ichinoe M, Mikami T, Yanagisawa N, Yoshida T, Hana K, Endou H, Okayasu I, Sengoku N, Ogata H, Saegusa M, Shibuya K, Murakumo Y. J Clin Pathol. 2021 Sep;74(9):589-595. doi: 10.1136/jclinpath-2020-206457. Epub 2020 Sep 9. PMID: 32907912

 

SSEA-3 and 4 are not essential for the induction or properties of mouse iPS cells.

Hamamura K, Hotta H, Murakumo Y, Shibuya H, Kondo Y, Furukawa K. J Oral Sci. 2020 Sep 26;62(4):393-396. doi: 10.2334/josnusd.19-0513. Epub 2020 Jul 17. PMID: 32684574

 

Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors.

Sakurai Y, Ichinoe M, Yoshida K, Nakazato Y, Saito S, Satoh M, Nakada N, Sanoyama I, Umezawa A, Numata Y, Shi-Xu J, Ichihara M, Takahashi M, Murakumo Y. Cancer Lett. 2020 Oct 1;489:100-110. doi: 10.1016/j.canlet.2020.06.001. Epub 2020 Jun 15. PMID: 32553781

 

Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma.

Nagashio R, Kuchitsu Y, Igawa S, Kusuhara S, Naoki K, Satoh Y, Ichinoe M, Murakumo Y, Saegusa M, Sato Y. Biomed Res. 2020;41(3):149-159. doi: 10.2220/biomedres.41.149. PMID: 32522932

 

Expression of CA2 and CA9 carbonic anhydrases in ulcerative colitis and ulcerative colitis-associated colorectal cancer.

Nakada N, Mikami T, Horie K, Nagashio R, Sakurai Y, Sanoyama I, Yoshida T, Sada M, Kobayashi K, Sato Y, Okayasu I, Murakumo Y. Pathol Int. 2020 Aug;70(8):523-532. doi: 10.1111/pin.12949. Epub 2020 May 14. PMID: 32410301

 

TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma.

Kuchitsu Y, Nagashio R, Igawa S, Kusuhara S, Tsuchiya B, Ichinoe M, Satoh Y, Naoki K, Murakumo Y, Saegusa M, Sato Y. Biomed Res. 2020;41(1):53-65. doi: 10.2220/biomedres.41.53. PMID: 32092740

 

EGFR mutation genotyping and ALK status determination in liquid-based cytology samples of non-small cell lung cancer.

Satoh Y, Matsuo Y, Kuba T, Yamashita K, Sawano M, Tozaka S, Yamazaki H, Sonoda D, Mikubo M, Naito M, Matsui Y, Shiomi K, Yoshida T, Murakumo Y. Virchows Arch. 2020 May;476(5):753-762. doi: 10.1007/s00428-019-02692-9. Epub 2019 Dec 10. PMID: 31823000

 

Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.

Hiyoshi Y, Sato Y, Ichinoe M, Nagashio R, Hagiuda D, Kobayashi M, Kusuhara S, Igawa S, Shiomi K, Goshima N, Murakumo Y, Saegusa M, Satoh Y, Masuda N, Naoki K. Thorac Cancer. 2019 Nov;10(11):2142-2151. doi: 10.1111/1759-7714.13200. Epub 2019 Oct 3. PMID: 31583841

 

CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.

Mii S, Enomoto A, Shiraki Y, Taki T, Murakumo Y, Takahashi M. Pathol Int. 2019 May;69(5):249-259. doi: 10.1111/pin.12798. Epub 2019 Jun 20. PMID: 31219232 Review.

 

Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma.

Hagiuda D, Nagashio R, Ichinoe M, Tsuchiya B, Igawa S, Naoki K, Satoh Y, Murakumo Y, Saegusa M, Sato Y. Biomed Res. 2019;40(1):17-27. doi: 10.2220/biomedres.40.17. PMID: 30787260

 

Cytoskeleton-Associated Protein 4 Is a Novel Serodiagnostic Marker for Lung Cancer.

Yanagita K, Nagashio R, Jiang SX, Kuchitsu Y, Hachimura K, Ichinoe M, Igawa S, Fukuda E, Goshima N, Satoh Y, Murakumo Y, Saegusa M, Sato Y. Am J Pathol. 2018 Jun;188(6):1328-1333. doi: 10.1016/j.ajpath.2018.03.007. Epub 2018 May 8. PMID: 29751934

 

CD109 and squamous cell carcinoma.

Qi R, Dong F, Liu Q, Murakumo Y, Liu J. J Transl Med. 2018 Apr 6;16(1):88. doi: 10.1186/s12967-018-1461-3. PMID: 29625613

 

Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma.

Matsumoto T, Nagashio R, Ryuge S, Igawa S, Kobayashi M, Fukuda E, Goshima N, Ichinoe M, Jiang SX, Satoh Y, Masuda N, Murakumo Y, Saegusa M, Sato Y. Pathol Int. 2018 Apr;68(4):232-240. doi: 10.1111/pin.12646. Epub 2018 Feb 12. PMID: 29431238

 

Prognostic significance of S100A16 subcellular localization in lung adenocarcinoma.

Kobayashi M, Nagashio R, Saito K, Aguilar-Bonavides C, Ryuge S, Katono K, Igawa S, Tsuchiya B, Jiang SX, Ichinoe M, Murakumo Y, Saegusa M, Satoh Y, Sato Y. Hum Pathol. 2018 Apr;74:148-155. doi: 10.1016/j.humpath.2018.01.001. Epub 2018 Jan 7. PMID: 29320753

 

S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma.

Katono K, Sato Y, Kobayashi M, Nagashio R, Ryuge S, Igawa S, Ichinoe M, Murakumo Y, Saegusa M, Masuda N.

 

Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma.

Katono K, Sato Y, Kobayashi M, Saito K, Nagashio R, Ryuge S, Igawa S, Nakashima H, Shiomi K, Satoh Y, Ichinoe M, Murakumo Y, Saegusa M, Masuda N. Oncol Res Treat. 2017;40(10):594-602. doi: 10.1159/000478100. Epub 2017 Sep 19. PMID: 28950283

 

Significance of perivascular tumour cells defined by CD109 expression in progression of glioma.

Shiraki Y, Mii S, Enomoto A, Momota H, Han YP, Kato T, Ushida K, Kato A, Asai N, Murakumo Y, Aoki K, Suzuki H, Ohka F, Wakabayashi T, Todo T, Ogawa S, Natsume A, Takahashi M. J Pathol. 2017 Dec;243(4):468-480. doi: 10.1002/path.4981. Epub 2017 Nov 1. PMID: 28888050

 

Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers.

Ryuge S, Sato Y, Nagashio R, Hiyoshi Y, Katono K, Igawa S, Nakashima H, Shiomi K, Ichinoe M, Murakumo Y, Saegusa M, Satoh Y, Masuda N. PLoS One. 2017 Mar 30;12(3):e0173886. doi: 10.1371/journal.pone.0173886. eCollection 2017. PMID: 28358810 Free PMC article.

 

Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer.

Igawa S, Sato Y, Ryuge S, Ichinoe M, Katono K, Hiyoshi Y, Otani S, Nagashio R, Nakashima H, Katagiri M, Sasaki J, Murakumo Y, Satoh Y, Masuda N.

 

Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations.

Igawa S, Ryuge S, Ichinoe M, Nakashima H, Otani S, Nakahara Y, Fukui T, Sasaki J, Kubota M, Katagiri M, Murakumo Y, Satoh Y, Sato Y, Masuda N. Oncol Res Treat. 2017;40(1-2):7-13. doi: 10.1159/000455147. Epub 2017 Jan 25. PMID: 28118631

 

CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.

Yokoyama M, Ichinoe M, Okina S, Sakurai Y, Nakada N, Yanagisawa N, Jiang SX, Numata Y, Umezawa A, Miyazaki K, Higashihara M, Murakumo Y. Int J Hematol. 2017 May;105(5):614-622. doi: 10.1007/s12185-016-2173-1. Epub 2016 Dec 28. PMID: 28032275

 

Suppression of skin tumorigenesis in CD109-deficient mice.

Sunagawa M, Mii S, Enomoto A, Kato T, Murakumo Y, Shiraki Y, Asai N, Asai M, Nagino M, Takahashi M. Oncotarget. 2016 Dec 13;7(50):82836-82850. doi: 10.18632/oncotarget.12653. PMID: 27756876 Free PMC article.

 

CD109 is a component of exosome secreted from cultured cells.

Sakakura H, Mii S, Hagiwara S, Kato T, Yamamoto N, Hibi H, Takahashi M, Murakumo Y. Biochem Biophys Res Commun. 2016 Jan 22;469(4):816-22. doi: 10.1016/j.bbrc.2015.12.063. Epub 2015 Dec 18. PMID: 26707640

 

High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab.

Okina S, Yanagisawa N, Yokoyama M, Sakurai Y, Numata Y, Umezawa A, Higashihara M, Murakumo Y. Int J Hematol. 2015 Dec;102(6):662-9. doi: 10.1007/s12185-015-1880-3. Epub 2015 Oct 8. PMID: 26449786

 

L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.

Ichinoe M, Yanagisawa N, Mikami T, Hana K, Nakada N, Endou H, Okayasu I, Murakumo Y. Pathol Res Pract. 2015 Jul;211(7):533-8. doi: 10.1016/j.prp.2015.03.007. Epub 2015 Apr 7. PMID: 25908107

 

L-amino acid transporter 1 may be a prognostic marker for local progression of prostatic cancer under expectant management.

Yanagisawa N, Satoh T, Hana K, Ichinoe M, Nakada N, Endou H, Okayasu I, Murakumo Y. Cancer Biomark. 2015;15(4):365-74. doi: 10.3233/CBM-150486. PMID: 25835180

 

Diagnostic and prognostic significances of MUC5B and TTF-1 expressions in resected non-small cell lung cancer.

Nagashio R, Ueda J, Ryuge S, Nakashima H, Jiang SX, Kobayashi M, Yanagita K, Katono K, Satoh Y, Masuda N, Murakumo Y, Hachimura K, Sato Y. Sci Rep. 2015 Mar 3;5:8649. doi: 10.1038/srep08649. PMID: 25733373 Free PMC article.

 

CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.

Zhang JM, Murakumo Y, Hagiwara S, Jiang P, Mii S, Kalyoncu E, Saito S, Suzuki C, Sakurai Y, Numata Y, Yamamoto T, Takahashi M. Biochem Biophys Res Commun. 2015 Apr 3;459(2):252-258. doi: 10.1016/j.bbrc.2015.02.093. Epub 2015 Feb 25. PMID: 25724945 Free article.

 

Regulation of cargo-selective endocytosis by dynamin 2 GTPase-activating protein girdin.

Weng L, Enomoto A, Miyoshi H, Takahashi K, Asai N, Morone N, Jiang P, An J, Kato T, Kuroda K, Watanabe T, Asai M, Ishida-Takagishi M, Murakumo Y, Nakashima H, Kaibuchi K, Takahashi M. EMBO J. 2014 Sep 17;33(18):2098-112. doi: 10.15252/embj.201488289. Epub 2014 Jul 24. PMID: 25061227 Free PMC article.

 

High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas.

Yanagisawa N, Hana K, Nakada N, Ichinoe M, Koizumi W, Endou H, Okayasu I, Murakumo Y. Cancer Med. 2014 Oct;3(5):1246-55. doi: 10.1002/cam4.272. Epub 2014 Jun 2. PMID: 24890221 Free PMC article.

 

TRIM27/MRTF-B-dependent integrin β1 expression defines leading cells in cancer cell collectives.

Kato T, Enomoto A, Watanabe T, Haga H, Ishida S, Kondo Y, Furukawa K, Urano T, Mii S, Weng L, Ishida-Takagishi M, Asai M, Asai N, Kaibuchi K, Murakumo Y, Takahashi M. Cell Rep. 2014 May 22;7(4):1156-67. doi: 10.1016/j.celrep.2014.03.068. Epub 2014 May 1. PMID: 24794433

 

Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells.

Niimi K, Murakumo Y, Watanabe N, Kato T, Mii S, Enomoto A, Asai M, Asai N, Yamamoto E, Kajiyama H, Shibata K, Kikkawa F, Takahashi M. Cancer Sci. 2014 May;105(5):545-52. doi: 10.1111/cas.12390. Epub 2014 Apr 7. PMID: 24597627 Free PMC article.

 

Detection of a soluble form of CD109 in serum of CD109 transgenic and tumor xenografted mice.

Sakakura H, Murakumo Y, Mii S, Hagiwara S, Kato T, Asai M, Hoshino A, Yamamoto N, Sobue S, Ichihara M, Ueda M, Takahashi M. PLoS One. 2014 Jan 6;9(1):e83385. doi: 10.1371/journal.pone.0083385. eCollection 2014. PMID: 24400073 Free PMC article.

 

Association of D2-40 and MMP-1 expression with cyst formation in lung metastatic lesions of cutaneous angiosarcoma on the scalp: immunohistochemical analysis of 23 autopsy cases.

Masuzawa M, Mikami T, Numata Y, Tokuyama W, Masuzawa M, Murakumo Y, Okayasu I, Katsuoka K. Hum Pathol. 2013 Dec;44(12):2751-9. doi: 10.1016/j.humpath.2013.07.022. Epub 2013 Oct 11. PMID: 24125743

Small gastrointestinal stromal tumor in the stomach: identification of precursor for clinical gastrointestinal stromal tumor using c-kit and α-smooth muscle actin expression.

Mikami T, Nemoto Y, Numata Y, Hana K, Nakada N, Ichinoe M, Murakumo Y, Okayasu I. Hum Pathol. 2013 Dec;44(12):2628-35. doi: 10.1016/j.humpath.2013.07.020. Epub 2013 Oct 10. PMID: 24119563
Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
Miyachi H, Mii S, Enomoto A, Murakumo Y, Kato T, Asai N, Komori K, Takahashi M. J Vasc Surg. 2014 Aug;60(2):479-489.e5. doi: 10.1016/j.jvs.2013.06.080. Epub 2013 Aug 12. PMID: 23948670

The REV7 subunit of DNA polymerase ζ is essential for primordial germ cell maintenance in the mouse.

Watanabe N, Mii S, Asai N, Asai M, Niimi K, Ushida K, Kato T, Enomoto A, Ishii H, Takahashi M, Murakumo Y. J Biol Chem. 2013 Apr 12;288(15):10459-71. doi: 10.1074/jbc.M112.421966. Epub 2013 Mar 5. PMID: 23463509 Free PMC article.
Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer.
Horio M, Kato T, Mii S, Enomoto A, Asai M, Asai N, Murakumo Y, Shibata K, Kikkawa F, Takahashi M. Cancer Med. 2012 Oct;1(2):218-29. doi: 10.1002/cam4.32. Epub 2012 Sep 13. PMID: 23342271 Free PMC article.
Similar phenotypes of Girdin germ-line and conditional knockout mice indicate a crucial role for Girdin in the nestin lineage.
Asai M, Asai N, Murata A, Yokota H, Ohmori K, Mii S, Enomoto A, Murakumo Y, Takahashi M. Biochem Biophys Res Commun. 2012 Oct 5;426(4):533-8. doi: 10.1016/j.bbrc.2012.08.122. Epub 2012 Sep 4. PMID: 22974978
Epidermal hyperplasia and appendage abnormalities in mice lacking CD109.
Mii S, Murakumo Y, Asai N, Jijiwa M, Hagiwara S, Kato T, Asai M, Enomoto A, Ushida K, Sobue S, Ichihara M, Takahashi M. Am J Pathol. 2012 Oct;181(4):1180-9. doi: 10.1016/j.ajpath.2012.06.021. Epub 2012 Jul 27. PMID: 22846721

Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression.

Hagikura M, Murakumo Y, Hasegawa M, Jijiwa M, Hagiwara S, Mii S, Hagikura S, Matsukawa Y, Yoshino Y, Hattori R, Wakai K, Nakamura S, Gotoh M, Takahashi M. Pathol Int. 2010 Nov;60(11):735-43. doi: 10.1111/j.1440-1827.2010.02592.x. Epub 2010 Oct 6. PMID: 20946523

Crystal structure of human REV7 in complex with a human REV3 fragment and structural implication of the interaction between DNA polymerase zeta and REV1.

Hara K, Hashimoto H, Murakumo Y, Kobayashi S, Kogame T, Unzai S, Akashi S, Takeda S, Shimizu T, Sato M. J Biol Chem. 2010 Apr 16;285(16):12299-307. doi: 10.1074/jbc.M109.092403. Epub 2010 Feb 17. PMID: 20164194 Free PMC article.

Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.

Hagiwara S, Murakumo Y, Mii S, Shigetomi T, Yamamoto N, Furue H, Ueda M, Takahashi M. Oncogene. 2010 Apr 15;29(15):2181-91. doi: 10.1038/onc.2009.506. Epub 2010 Jan 25. PMID: 20101215
Overlapping in short motif sequences for binding to human REV7 and MAD2 proteins.
Hanafusa T, Habu T, Tomida J, Ohashi E, Murakumo Y, Ohmori H. Genes Cells. 2010 Mar;15(3):281-96. doi: 10.1111/j.1365-2443.2009.01380.x. Epub 2010 Jan 19. PMID: 20088965 Free article.
Up-regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity.
Hagiwara S, Murakumo Y, Sato T, Shigetomi T, Mitsudo K, Tohnai I, Ueda M, Takahashi M. Cancer Sci. 2008 Oct;99(10):1916-23. doi: 10.1111/j.1349-7006.2008.00949.x. PMID: 19016750 Free article.
CD109 expression in basal-like breast carcinoma.
Hasegawa M, Moritani S, Murakumo Y, Sato T, Hagiwara S, Suzuki C, Mii S, Jijiwa M, Enomoto A, Asai N, Ichihara S, Takahashi M. Pathol Int. 2008 May;58(5):288-94. doi: 10.1111/j.1440-1827.2008.02225.x. PMID: 18429827

High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.

Sato T, Murakumo Y, Hagiwara S, Jijiwa M, Suzuki C, Yatabe Y, Takahashi M. Pathol Int. 2007 Nov;57(11):719-24. doi: 10.1111/j.1440-1827.2007.02168.x. PMID: 17922683
CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells.
Hasegawa M, Hagiwara S, Sato T, Jijiwa M, Murakumo Y, Maeda M, Moritani S, Ichihara S, Takahashi M. Pathol Int. 2007 May;57(5):245-50. doi: 10.1111/j.1440-1827.2007.02097.x. PMID: 17493171
Analyses of ultraviolet-induced focus formation of hREV1 protein.
Murakumo Y, Mizutani S, Yamaguchi M, Ichihara M, Takahashi M. Genes Cells. 2006 Mar;11(3):193-205. doi: 10.1111/j.1365-2443.2006.00938.x. PMID: 16483309
CD109 expression in squamous cell carcinoma of the uterine cervix.
Zhang JM, Hashimoto M, Kawai K, Murakumo Y, Sato T, Ichihara M, Nakamura S, Takahashi M. Pathol Int. 2005 Apr;55(4):165-9. doi: 10.1111/j.1440-1827.2005.01807.x. PMID: 15826242
Interaction of hREV1 with three human Y-family DNA polymerases.
Ohashi E, Murakumo Y, Kanjo N, Akagi J, Masutani C, Hanaoka F, Ohmori H. Genes Cells. 2004 Jun;9(6):523-31. doi: 10.1111/j.1356-9597.2004.00747.x. PMID: 15189446 Free article.

Expression of CD109 in human cancer.

Hashimoto M, Ichihara M, Watanabe T, Kawai K, Koshikawa K, Yuasa N, Takahashi T, Yatabe Y, Murakumo Y, Zhang JM, Nimura Y, Takahashi M. Oncogene. 2004 Apr 29;23(20):3716-20. doi: 10.1038/sj.onc.1207418. PMID: 15116102
The property of DNA polymerase zeta: REV7 is a putative protein involved in translesion DNA synthesis and cell cycle control.
Murakumo Y. Mutat Res. 2002 Dec 29;510(1-2):37-44. doi: 10.1016/s0027-5107(02)00250-6. PMID: 12459441 Review.
Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7.
Murakumo Y, Ogura Y, Ishii H, Numata S, Ichihara M, Croce CM, Fishel R, Takahashi M. J Biol Chem. 2001 Sep 21;276(38):35644-51. doi: 10.1074/jbc.M102051200. Epub 2001 Aug 2. PMID: 11485998
A human REV7 homolog that interacts with the polymerase zeta catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2.
Murakumo Y, Roth T, Ishii H, Rasio D, Numata S, Croce CM, Fishel R. J Biol Chem. 2000 Feb 11;275(6):4391-7. doi: 10.1074/jbc.275.6.4391. PMID: 10660610
Cloning of the cDNA encoding mast cell tryptase of Mongolian gerbil, Meriones unguiculatus, and its preferential expression in the intestinal mucosa.
Murakumo Y, Ide H, Itoh H, Tomita M, Kobayashi T, Maruyama H, Horii Y, Nawa Y. Biochem J. 1995 Aug 1;309 ( Pt 3)(Pt 3):921-6. doi: 10.1042/bj3090921. PMID: 7639711 Free PMC article.

Linkage of the athymic nude locus with the myeloperoxidase locus in the rat.

Murakumo Y, Takahashi M, Hayashi N, Taguchi M, Arakawa A, Sharma N, Sakata K, Saito M, Amo H, Katoh H, et al. Pathol Int. 1995 Apr;45(4):261-5. doi: 10.1111/j.1440-1827.1995.tb03454.x. PMID: 7550994

Chromosomal mapping of genetic locus associated with thymus-size enlargement in BUF/Mna rats.

Murakumo Y, Takahashi M, Arakawa A, Saito M, Amo H, Katoh H, Matsuyama M. Jpn J Cancer Res. 1993 Aug;84(8):838-40. doi: 10.1111/j.1349-7006.1993.tb02054.x. PMID: 8407546 Free PMC article.

 

powered by Quick Homepage Maker 4.53
based on PukiWiki 1.4.7 License is GPL. QHM

最新の更新 RSS  Valid XHTML 1.0 Transitional